164 related articles for article (PubMed ID: 25153485)
1. The effect of the novel tellurium compound AS101 on autoimmune diseases.
Halpert G; Sredni B
Autoimmun Rev; 2014 Dec; 13(12):1230-5. PubMed ID: 25153485
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulating tellurium compounds as anti-cancer agents.
Sredni B
Semin Cancer Biol; 2012 Feb; 22(1):60-9. PubMed ID: 22202556
[TBL] [Abstract][Full Text] [Related]
3. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
[TBL] [Abstract][Full Text] [Related]
4. Tellurium Compounds Prevent and Reverse Type-1 Diabetes in NOD Mice by Modulating α4β7 Integrin Activity, IL-1β, and T Regulatory Cells.
Yossipof TE; Bazak ZR; Kenigsbuch-Sredni D; Caspi RR; Kalechman Y; Sredni B
Front Immunol; 2019; 10():979. PubMed ID: 31191514
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional activity of a small tellurium redox immunomodulator compound, AS101, on dextran sodium sulfate-induced murine colitis.
Halpert G; Eitan T; Voronov E; Apte RN; Rath-Wolfson L; Albeck M; Kalechman Y; Sredni B
J Biol Chem; 2014 Jun; 289(24):17215-27. PubMed ID: 24764299
[TBL] [Abstract][Full Text] [Related]
6. Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound, AS101.
Frei GM; Kremer M; Hanschmann KM; Krause S; Albeck M; Sredni B; Schnierle BS
Br J Dermatol; 2008 Mar; 158(3):578-86. PubMed ID: 18241275
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulatory molecules: role in the antitumoral effects of AS101.
Kalechman Y; Sredni B
J Immunol; 1996 Jul; 157(2):589-97. PubMed ID: 8752906
[TBL] [Abstract][Full Text] [Related]
8. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101.
Sredni B; Tichler T; Shani A; Catane R; Kaufman B; Strassmann G; Albeck M; Kalechman Y
J Natl Cancer Inst; 1996 Sep; 88(18):1276-84. PubMed ID: 8797767
[TBL] [Abstract][Full Text] [Related]
9. Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues.
Chiaverini L; Cirri D; Tolbatov I; Corsi F; Piano I; Marrone A; Pratesi A; Marzo T; La Mendola D
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886853
[TBL] [Abstract][Full Text] [Related]
10. The immunomodulatory tellurium compound ammonium trichloro (dioxoethylene-O,O') tellurate reduces anxiety-like behavior and corticosterone levels of submissive mice.
Gross M; Stanciu E; Kenigsbuch-Sredni D; Sredni B; Pinhasov A
Behav Pharmacol; 2017 Sep; 28(6):458-465. PubMed ID: 28590303
[TBL] [Abstract][Full Text] [Related]
11. Ammonium trichloro [1,2-ethanediolato-O,O']-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway.
Vishwakarma P; Parmar N; Chandrakar P; Sharma T; Kathuria M; Agnihotri PK; Siddiqi MI; Mitra K; Kar S
Cell Mol Life Sci; 2018 Feb; 75(3):563-588. PubMed ID: 28900667
[TBL] [Abstract][Full Text] [Related]
12. The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme.
Brodsky M; Yosef S; Galit R; Albeck M; Longo DL; Albeck A; Sredni B
J Interferon Cytokine Res; 2007 Jun; 27(6):453-62. PubMed ID: 17572009
[TBL] [Abstract][Full Text] [Related]
13. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.
Kalechman Y; Gafter U; Gal R; Rushkin G; Yan D; Albeck M; Sredni B
J Immunol; 2002 Jul; 169(1):384-92. PubMed ID: 12077268
[TBL] [Abstract][Full Text] [Related]
14. The organotellurium compound ammonium trichloro(dioxoethylene-o,o')tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice.
Okun E; Dikshtein Y; Carmely A; Saida H; Frei G; Sela BA; Varshavsky L; Ofir A; Levy E; Albeck M; Sredni B
FEBS J; 2007 Jun; 274(12):3159-70. PubMed ID: 17521335
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3.
Kalechman Y; Gafter U; Weinstein T; Chagnac A; Freidkin I; Tobar A; Albeck M; Sredni B
J Biol Chem; 2004 Jun; 279(23):24724-32. PubMed ID: 15001575
[TBL] [Abstract][Full Text] [Related]
16. The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis.
Xie L; Chen J; McMickle A; Awar N; Nady S; Sredni B; Drew PD; Yu S
J Neuroimmunol; 2014 Aug; 273(1-2):31-41. PubMed ID: 24975323
[TBL] [Abstract][Full Text] [Related]
17. Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels.
Kalechman Y; Gafter U; Da JP; Albeck M; Alarcon-Segovia D; Sredni B
J Immunol; 1997 Sep; 159(6):2658-67. PubMed ID: 9300685
[TBL] [Abstract][Full Text] [Related]
18. Resolution of inflammation-related apoptotic processes by the synthetic tellurium compound, AS101 following liver injury.
Brodsky M; Hirsh S; Albeck M; Sredni B
J Hepatol; 2009 Sep; 51(3):491-503. PubMed ID: 19595469
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory effects of the tellurium redox modulating compound, AS101, are associated with regulation of NFkappaB signaling pathway and nitric oxide induction in macrophages.
Brodsky M; Halpert G; Albeck M; Sredni B
J Inflamm (Lond); 2010 Jan; 7(1):3. PubMed ID: 20205748
[TBL] [Abstract][Full Text] [Related]
20. AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.
Bing SJ; Shemesh I; Chong WP; Horai R; Jittayasothorn Y; Silver PB; Sredni B; Caspi RR
J Autoimmun; 2019 Jun; 100():52-61. PubMed ID: 30853312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
